Next, we used a specific siRNA to knock down MLC and found that cell migration was not improved in HNSCC cells treated with CCL2 (Fig. 3E, F) although the level of GTP-bound Rac1 was upregulated (Fig. 3G). Here, CCL2 is linked to head and neck squamous cell carcinoma.